Evaluation of Average CT to reduce the artifact in PET/CT

Slides:



Advertisements
Similar presentations
FDG-PET/CT PATTERNS AND PREVALENCE OF PERITONEAL SPREAD IN OVARIAN CANCER Srour SF 1, Bar-Shalom R 2 Srour SF 1, Bar-Shalom R 2 1 Department of Diagnostic.
Advertisements

-- CTSA at RSNA 2010 PET/CT Analysis using 3D Slicer Jeffrey Yap PhD Ron Kikinis MD Wendy Plesniak PhD PET/CT Visualization and Analysis.
Introduction to PET/CT in Oncology: Practical Aspects Jeffrey T. Yap, PhD Department of Imaging Dana-Farber Cancer Institute.
Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?
Advances in Early Diagnosis and Treatment of Cancer July 17, 2007.
Transforming Static CT in Gated PET/CT Studies to Multiple Respiratory Phases M Dawood, F Büther, N Lang, X Jiang, KP Schäfers Department of Nuclear Medicine,
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
18 F-FET PET Compared with 18 F- FDG PET and CT in Patients with Head and Neck Cancer Present by Intern 羅穎駿 Journal of Nuclear Medicine Vol. 47 No
Mirada Casebook Case study 1: Colorectal. Indication: T3 N1 R0 sigmoid colectomy August 2009 CT demonstrated solitary segment VI/VII liver metastasis.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
-- CTSA at RSNA 2009 PET/CT Analysis using 3D Slicer Jeffrey Yap PhD Ron Kikinis MD Wendy Plesniak PhD Slicer3 Training Compendium.
The Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non- Small Cell Lung Cancer Malcolm Mattes, Salma Ahsanuddin,
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
Jeffrey Yap, PhD Ron Kikinis, MD Wendy Plesniak, PhD -1- CTSA at RSNA 2009 PET/CT Analysis using 3D Slicer Jeffrey Yap PhD Ron Kikinis MD Wendy Plesniak.
Prognostic Value of Tumor Hypoxia,
Prognostic Value of PET Using 18F-FDG in Hodgkin’s Disease for Posttreatment Evaluation J Nucl Med 2003; 44:1225–1231 Intern 魏敬庭.
RESULTS 4D-Computed Tomography Guided Treatment Planning for Intrahepatic Tumors Yen-Lin Chen, M.D. 1,2, Eike Rietzel, Ph.D. 1,2, Judith Adams 1,2, John.
Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.
WELCOME. PET/CT CASE REVIEW COURSE JANUARY 31 ST PASADENA CONVENTION CENTER LOS ANGELES RADIOLOGIC SOCIETY MID WINTER MEETING.
Correlation Evaluation of a Tumor Tracking System Using Multiple External Markers Hui Yan, Fang-Fang Yin, et al (Duke University Med. Ctr.)
Albert J. Chang, MD, PhD 1 Farrokh Dehdashti, MD 2 Perry W. Grigsby, MD, MS 1 Department of Radiation Oncology 1 Department of Radiology and Nuclear Medicine.
Can PET/CT and PET FDG predict Chemotherapy response in lung cancer patients? By: Megan Broscious.
Nuclear Medicine Physics Jerry Allison, Ph.D. Department of Radiology Medical College of Georgia Image Artifacts in Nuclear Medicine Part B.
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Carmel McDerby Clatterbridge Centre for Oncology, Merseyside,UK
Beth Israel plugin : A new free software tool for metabolic tumor volume calculation on PET/CT Objective: Salim Kanoun 1,2, Ilan Tal 3, Alina Berriolo-Reidinger.
Thursday Case of the Day The arrow indicates a region of high apparent FDG uptake posterior to the bladder. What is the cause of this artifact? a) attenuation.
PET Scanner Calibration Using a Small Ga68/Ge68 Source
Authors: Syed H. Jafri ¹, Angel I. Blanco¹, Bonnie A. Labdi², Shan Guo¹. UT Houston department of medicine, Division of Oncology Department of Pharmacy.
18 F-FDG Colonic Uptake by Oral Anti- Diabetic Drugs in PET/CT Scan Sang Gyu Kim, Hoon Hee Park, Jung Yul Kim, Young Kag Bahn Han Sang Lim, Jae Sam Kim,
Segmentation of 3D microPET Images of the Rat Brain by Hybrid GMM and KDE Tai-Been Chen Department of Medical Imaging and Radiological Science,
JESÚS SILVA-RODRÍGUEZ, PABLO AGUIAR, INÉS DOMÍNGUEZ-PRADO, MICHEL HERRANZ, ÁLVARO RUIBAL 18F-Choline: Is shine-through effect an issue for prostate SUV.
The Optimization of Reconstruction Method Reducing Partial Volume Effect in PET/CT 3D Image Acquisition Department of Nuclear Medicine, Samsung Medical.
Background: Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a complex growth pattern. Imaging plays a crucial role in diagnosis.
A Study on the Determination of Scan Speed in Whole Body Bone Scan Applying Oncoflash Gwang Gil Yang Department of Nuclear Medicine, Asan Medical Center,
University of Pennsylvania Department of Orthopaedic Surgery Joseph King, Eileen Crawford, Abass Alavi, Arthur Staddon, Lee Hartner, Richard Lackman and.
Common Carotid Artery Molecular Calcification Assessed by 18F-NaF PET/CT is Associated with Increased Cardiovascular Disease Risk: Results from the CAMONA.
Dr. Malhar Patel DNB (Radiation Oncology)
Physica Medica 32 (2016) 1570–1574 報告人:王俊淵
Normal Chest and Abdominal Tumor Motion in Radiation Therapy Treatment Planning: A Review of Recommendations and Investigation of Current Practices Dylan.
You Zhang, Jeffrey Meyer, Joubin Nasehi Tehrani, Jing Wang
Impact of moving target on measurement accuracy in 3D and 4D PET imaging—a phantom study  Yunfeng Cui, PhD, James Bowsher, PhD, Jing Cai, PhD, Fang-Fang.
Impact of Obesity on Medical Imaging and Image-Guided Intervention
Thursday Case of the Day
The Accuracy of the Table Movement During A Whole Body Scan
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Moo seok Lee Department of nuclear medicine, Pusan University Hospital
Integration of Positron Emission Mammography (PEM)
Monday Physics Case of the Day Answers (1 of 3) Paul E
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Tuesday Case of the Day Physics History: A B MIP
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Standardized Uptake Values in FDG PET/CT for Prosthetic.
18F-FDG Colonic Uptake by Oral Anti-Diabetic Drugs in PET/CT Scan
Learning About PET/CT Scans:
Radiation Oncology Department, Bank of Cyprus Oncology Center.
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
Future of Thoracic PET Scanning
Clinical and Translational Radiation Oncology
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
Department of Nuclear Medicine Asan Medical Center, Seoul, Korea
Future of Thoracic PET Scanning
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma  Ho Yun Lee, MD, PhD, So Won Lee, MD, Kyung.
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.
Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma  Ho Yun Lee, MD, PhD, So Won Lee, MD, Kyung.
The evaluation of clinical usefulness on application of Half-time acquisition factor in Gated Cardiac Blood Pool scan Dong-Hun Lee.
Improving Image Accuracy of ROI in CT Using Prior Image
The precision test based on states of a Bone Mineral Density
Presentation transcript:

Evaluation of Average CT to reduce the artifact in PET/CT Department of Nuclear Medicine Asan Medical Center Kim Jung Sun

Introduction PET shows accuracy in staging, restaging of cancer and assessment of treatment response. To predict treatment response, SUV have been used in cancer. Respiratory motion often hampers SUV in FDG PET/CT images. Respiratory motion often makes artifacts of PET/CT image.

Introduction Artifact is due to discrepancy of the diaphragm position. Because of different scan time. CT scan takes a few seconds, but PET scan takes 3~5min per bed. Breathing Cycle PET Scan CT scan

To reduce respiration artifact Introduction To reduce respiration artifact Equipments Methods - Pressure Sensor - Spirometer - Temperature Sensor - RPM Respiratory Gating System -Deep-Inspiration BH PET/CT -Attenuation correction with average CT(ACT)

Cine CT Introduction Average CT AC of PET data with ACT has been proposed for improving the artifact by Tinsu Pan. Cine CT Average CT Improved artifact average Attenuation Correction Cine CT acquires multiple CT images in on breathing cycle.

Introduction Cine CT AC MAP average ACT HCT *Helical CT( HCT)

To evaluate usefulness of ACT Introduction • Purpose To evaluate usefulness of ACT for AC of PET data

Object Materials and Methods Equipments Analysis Software Whole Body PET/CT 13 Patients Mean Age=61.6 9 Lung cancer(20 tumors),4 Liver cancer(8 tumors) Object Equipments Discovery STe8, GE helthcare Workstation V4.3 Volume viewer ,GE helthcare Analysis Software

Materials and Methods • Acquisition Procedure ACT Scan CT Scan Toposcan CT Scan 120kV, auto mA ACT Scan (Lower thorax) 120kV,10mA 2cm/5.9s Cine duration PET Scan 3min/bed

Materials and Methods • Measurement of the artifact Measured the highest magnitude of artifact slice by slice with coronal images.

Materials and Methods • Measurement of SUVmax ACT HCT Measured max SUV of primary tumors. ROIs were set to include tumor using 3D box tool with coronal and axial image. Measured maximum SUV of primary tumors. ROIs were set to include tumor using 3D box with coronal and axial image.

Materials and Methods • Statistical analysis paired t-test and Wilcoxon rank sum test SPSS v12.0 Attenuation Correction With HCT Attenuation Correction With ACT p values <0.05 were considered statistically significant.

Result • Frequency of artifact • Magnitude of artifact HCT ACT 2 / 13 8 / 13 2 / 13 HCT ACT • Magnitude of artifact

Result • Example of breathing artifact HCT ACT Breathing artifact was removed in AC with ACT image.

Result • SUVmax of Lung 13% n SUV Mean±SD Differnce %Differnce t p HCT 20 5.7±3.4 0.3±0.4 5.6±5.3% -3.472 0.03 ACT 6.0 ±3.5 13%

Result • SUVmax of Middle Lung • SUVmax of Lower Lung n SUV Mean±SD Differnce %Differnce z p HCT 9 5.2±2.8 0.2±0.4 4.6±6.6% -1.005a 0.315 ACT 5.4±3.0 • SUVmax of Lower Lung n SUV Mean±SD Differnce %Differnce t p HCT 11 6.1±3.8 0.3±0.3 6.4±4.0% -3.472 0.03 ACT 6.5±3.8

Result • SUVmax of Liver 9% n SUV Mean±SD Differnce %Differnce z p HCT 8 5.6±2.2 0.3±0.3 3.9±3.1% -2.636a 0.08 ACT 5.9±2.5

Result • SUVmean of Background n SUV Mean±SD Differnce %Differnce t p HCT 13 1.1±0.2 0.0±0.0 -0.4±4.7% 0.562 0.584 ACT

Limitation • We could not control patient breath regularly during the scan. - It could have probability that affect to comparison of artifact and SUV. • Limited number of patients(n=13). • Artifacts caused by overcorrection was not included. - We suspected one case to be a artifact caused by overcorrection. But we couldn’t decide artifact.

Conclusion If consider additional dose (7~8% of FDG PET/CT dose) The artifacts were significantly reduced in ACT. Accordingly these tumor were closer to diaphragm and had a probability of being corrected by ACT. Tumors located in Lower Lung and Liver showed increase in maxSUV. If consider additional dose (7~8% of FDG PET/CT dose) ACT may useful in treatment planning and monitoring treatment response.

Thank You